Shojiro Sawada

Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits

Masahiro Sugano, Naoki Makino, Shojiro Sawada et al. · Journal of Biological Chemistry · 1998 · 239 citations · Full text

Immunology, Hyperlipidemia, Oxidative Stress +18

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai et al. · Journal of Atherosclerosis and Thrombosis · 2023 · 235 citations · Full text

Atherosclerotic Cardiovascular, Epidemiology, Cardiovascular Epidemiology +12

Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial

Yuichiro Yamada, Hideki Katagiri, Yoshiyuki Hamamoto et al. · The Lancet Diabetes & Endocrinology · 2020 · 204 citations · Full text

Pioneer 9, Diabetes Management, Diabetes +9

Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient Mice

Kikuo Isoda, Shojiro Sawada, Norio Ishigami et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 162 citations · Full text

Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging

Atsushi Yonemura, Yukihiko Momiyama, Zahi A. Fayad et al. · Journal of the American College of Cardiology · 2005 · 151 citations

Vascular Disease, Cardiovascular Disease, Lipid-lowering Therapy +9